http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109419787-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-79 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 |
| filingDate | 2017-08-23^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-11-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-11-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109419787-B |
| titleOfInvention | Application of abietane diterpenoid compound |
| abstract | The invention discloses an application of a abietane diterpenoid compound, wherein the abietane diterpenoid compound has a chemical structure shown in a formula I: the compound of (1) or at least one of a hydrate, a pharmaceutically acceptable salt, a tautomer, a stereoisomer and a precursor compound thereof is used as an active ingredient for preparing a medicament or health-care food for inhibiting mast cell degranulation. Experiments show that: the compound shown in the formula I has the effect of remarkably inhibiting mast cell degranulation, is expected to be used as an active ingredient for preparing a medicament or health-care food for inhibiting the mast cell degranulation, and is further expected to be used as the active ingredient for preparing a mast cell stabilizer and preparing a medicament and health-care food for preventing or/and treating allergic diseases caused by the mast cell degranulation. |
| priorityDate | 2017-08-23^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 171 of 171.